Corresponding author: Johan Pallud, MD, Service de Neurochirurgie, Hôpital Sainte-Anne, 1 rue Cabanis, 75674 Paris Cedex 14, France.
Neuro Oncol. 2013 May;15(5):595-606. doi: 10.1093/neuonc/nos331. Epub 2013 Feb 7.
Supratentorial diffuse low-grade gliomas present a slow macroscopic tumor growth that can be quantified through the measurement of their velocity of diametric expansion. We assessed whether spontaneous velocity of diametric expansion can predict long-term outcomes as a categorical variable and as a continuous predictor.
A total of 407 adult patients with newly diagnosed supratentorial diffuse low-grade gliomas in adults were studied.
The mean spontaneous velocity of diametric expansion before first-line treatment was 5.8 ± 6.3 mm/year. During the follow-up (mean, 86.5 ± 59.4 months), 209 patients presented a malignant transformation, and 87 died. The malignant progression-free survival and the overall survival were significantly longer in cases of slow velocity of diametric expansion (median, 103 and 249 months, respectively) than in cases of fast velocity of diametric expansion (median, 35 and 91 months, respectively; P < .001). In multivariate analyses, spontaneous velocity of diametric expansion as a categorical variable (<4, ≥4 and <8, ≥8 and <12, ≥12 mm/year) was an independent prognostic factor for malignant progression-free survival (P < .001; hazard ratio, 3.87; 95% confidence interval [CI], 2.67-5.52) and for overall survival (P < .001; hazard ratio, 4.62; 95% CI, 2.58-7.97). Velocity of diametric expansion was also an independent prognostic factor for overall survival as a continuous predictor, showing a linear relationship between overall survival and spontaneous velocity of diametric expansion (hazard ratio, 1.09 per one unit increase; 95% CI, 1.06-1.12; P < .001).
Independent of the molecular status, the spontaneous velocity of diametric expansion allows the identification of rapidly growing diffuse low-grade gliomas (at higher risk of worsened evolution) during the pretherapeutic period and without delaying treatment.
幕上弥漫性低级别胶质瘤呈现出缓慢的宏观肿瘤生长,可以通过测量其直径膨胀速度来定量。我们评估了自发直径膨胀速度是否可以作为分类变量和连续预测因子来预测长期结果。
共研究了 407 名新诊断为幕上弥漫性低级别胶质瘤的成年患者。
一线治疗前自发直径膨胀速度的平均值为 5.8 ± 6.3mm/年。在随访期间(平均 86.5 ± 59.4 个月),209 例患者发生恶性转化,87 例患者死亡。低速直径膨胀的恶性无进展生存期和总生存期明显长于高速直径膨胀(中位数分别为 103 和 249 个月)(P <.001)。多变量分析显示,作为分类变量的自发直径膨胀速度(<4、≥4 和 <8、≥8 和 <12、≥12mm/年)是恶性无进展生存期的独立预后因素(P <.001;危险比 3.87;95%置信区间[CI] 2.67-5.52)和总生存期(P <.001;危险比 4.62;95% CI 2.58-7.97)。直径膨胀速度也是总生存期的独立预后因素作为连续预测因子,显示总生存期与自发直径膨胀速度之间存在线性关系(危险比,每增加一个单位增加 1.09;95% CI,1.06-1.12;P <.001)。
独立于分子状态,自发直径膨胀速度可以在治疗前期间识别快速生长的弥漫性低级别胶质瘤(具有恶化风险增加),而不会延迟治疗。